ImmunoGen, Inc.
METHODS OF TREATMENT USING ANTI-CD123 IMMUNOCONJUGATES

Last updated:

Abstract:

Methods of administering immunoconjugates that bind to CD123 are provided. The methods comprise administering an anti-CD123 immunoconjugate (e.g., IMGN632) to a subject in need thereof, for example, a patient with a hematologic malignancy, at a therapeutically effective dose regimen that results in treatment of the hematologic malignancy.

Status:
Application
Type:

Utility

Filling date:

30 Oct 2019

Issue date:

21 May 2020